Managing Treatment-Experienced Patients With Multidrug Resistance: Emerging Options and Strategies for Success
Source: Managing Treatment-Experienced Patients With Multidrug Resistance: Emerging Options and Strategies for Success

Table of Contents

 

Slideset

Managing Treatment-Experienced Patients With Multidrug Resistance: Emerging Options and Strategies for Success

In this downloadable slideset, Eric S. Daar, MD, and Daniel R. Kuritzkes, MD, review best practices in managing patients with multidrug-resistant HIV and discuss emerging investigational therapeutics for these patients.
Format: Microsoft PowerPoint (.ppt)
File size: 398 KB
Date posted: 4/28/2017
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017    
    For a newly-diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • How New Data From CROI 2017 May Renew Interest in NNRTIs

    Charles B. Hicks MD - 4/21/2017    
    How do phase III data on doravirine affect the potential for future therapy with NNRTIs?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017    1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had history of nonadherence and resistance?
  • Optimal ART During Late Pregnancy After a Break in Therapy

    Kathleen E. Squires MD - 4/20/2017    
    Which regimen may work best during the third trimester?
  • How New Data From CROI 2017 May Inform Treatment Simplification Options

    Charles B. Hicks MD - 4/20/2017    
    Is the switch to a 2-drug regimen in virologically suppressed HIV-infected patients feasible?